AINewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) Subsidiary Publishes Landmark Primer on Oncology Real-World Evidence

Fifty 1 Labs (OTC: FITY) through its subsidiary Fifty1 AI Labs, announced the publication of a landmark technical primer on transportability methods in oncology real-world evidence (RWE) in the Journal of Comparative Effectiveness Research. Co-authored by CTO Alind Gupta and CEO Paul Arora, the paper showcases how advanced statistical and AI-driven frameworks can bridge data gaps, accelerate health technology assessments, and improve global access to life-saving therapies. With the oncology RWE market projected to expand from $789 million in 2024 to $3.51 billion by 2035 at a CAGR of 14.7%, the publication underscores Fifty1 Labs’ leadership in advancing drug repurposing and treatment access, particularly in rare diseases and underserved regions.

To view the full press release, visit https://ibn.fm/WA13w

About Fifty1 AI Labs

Fifty1 AI Labs, a subsidiary of Fifty1 Labs, Inc. (OTC: FITY), is redefining drug discovery by using AI to unlock new potential in proven medicines. By repurposing safe, off-patent compounds, we accelerate smarter therapies that improve lives, reduce costs, and create lasting value for patients, partners, and forward-thinking investors.

For more information, visit the company’s website at https://fifty1labs.com/

About AINewsWire

AINewsWire (“AINW”) is a specialized communications platform with a focus on the latest advancements in artificial intelligence (“AI”), including the technologies, trends and trailblazers driving innovation forward. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, AINW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, AINW brings its clients unparalleled recognition and brand awareness.

AINW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from AINewsWire, text “AI” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit www.AINewsWire.com

Please see full terms of use and disclaimers on the AINewsWire website applicable to all content provided by AINW, wherever published or re-published: https://www.AINewsWire.com/Disclaimer

AINewsWire
Austin, Texas
www.AINewsWire.com
512.354.7000 Office
Editor@AINewsWire.com

AINewsWire is powered by IBN

AINewsWire

Share
Published by
AINewsWire
Breaks Categories: News

Recent Posts

AINewsBreaks – ZenaTech, Inc. (NASDAQ: ZENA) (FSE: 49Q) (BMV: ZENA) Subsidiary Signs MOU with Rattler Medical to Develop Drone-Based Battlefield Blood Delivery System 

ZenaTech (NASDAQ: ZENA)  (FSE: 49Q) (BMV: ZENA), a technology solutions provider specializing in artificial intelligence…

6 hours ago

AINewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTFD) Targets Initial Semiconductor Inspection Equipment Shipments, Potential $9 Million Revenue Opportunity 

Nightfood Holdings (OTCQB: NGTFD), doing business as TechForce Robotics, announced that its TechForce Advanced Manufacturing…

6 hours ago

AINewsBreaks – AZIO AI Holdings, Inc. (NASDAQ: AZIO) Confirms Atlas One Data Center Designed to Operate Independently of Texas Power Grid 

AZIO AI Holdings (NASDAQ: AZIO) confirmed that Atlas One, the first campus under its Project…

2 days ago

AINewsBreaks – Massimo Group (NASDAQ: MAMO) Reports Strong Interest in 2027 Warrior 1500XD and Sentinel 1500 Following SEMA Debut

Massimo Group (NASDAQ: MAMO) announced strong market interest following the official debut of its 2027 Warrior…

2 days ago

AINewsBreaks – Lantern Pharma (NASDAQ: LTRN) Publishes Phase 1a Glioblastoma Data, Advances LP-184 Combination Therapy Toward Phase 1b/2a Trial

Lantern Pharma (NASDAQ: LTRN) and its wholly owned subsidiary, Starlight Therapeutics, announced the publication of…

2 days ago

AINewsBreaks – Blaize Holdings, Inc. (NASDAQ: BZAI) Appoints Martin Costas Chief Operations Officer and Chief Financial Officer

Blaize (NASDAQ: BZAI), a provider of programmable, energy-efficient edge artificial intelligence (“AI”) computing solutions, announced…

3 days ago